Orphan Drug COVID–19 Mitigation Act of 2022
USA117th CongressHR-8641| House
| Updated: 8/2/2022
Josh Gottheimer
Democratic Representative
New Jersey
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Orphan Drug COVID-19 Mitigation Act of 2022 This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
Orphan Drug COVID–19 Mitigation Act of 2022
USA117th CongressHR-8641| House
| Updated: 8/2/2022
Orphan Drug COVID-19 Mitigation Act of 2022 This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Josh Gottheimer
Democratic Representative
New Jersey
Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted